United Therapeutics buy UBS Group AG
Start price
13.08.25
/
50%
€258.80
Target price
13.08.26
€355.41
Performance (%)
26.20%
Price
04.09.25
€326.60
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG currently has a performance of 26.20%. This prediction currently runs until 13.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| United Therapeutics | 28.174% |
| iShares Core DAX® | -2.076% |
| iShares Nasdaq 100 | -0.913% |
| iShares Nikkei 225® | -1.337% |
| iShares S&P 500 | -0.677% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Corporation (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $385.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€337.60
04.09.25
04.09.25
€480.20
04.09.26
04.09.26
-3.26%
04.09.25
04.09.25
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
33.80%
04.09.25
04.09.25
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
-8.08%
04.09.25
04.09.25
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25